Preclinical Studies Confirmed BP1001-A Mechanism of Action and Therapeutic Potential in Obesity and Type 2 DiabetesHOUSTON, Dec. 19, 2024 (GLOBE…
Real-time information aligns with first-party diagnostics to remediate data decay and reveal pristine insights into medical information NEW YORK, Dec.…
TOKYO, Dec. 18, 2024 /PRNewswire/ -- Tokyo Lifestyle Co., Ltd. ("Tokyo Lifestyle" or the "Company") (Nasdaq: TKLF), a retailer and…
Data from lowest dose level cohorts demonstrate a favorable safety and efficacy profile Data includes complete results from cohort 1…
- Improvements Across Measures of Behavior, Function, Cognition and Movement - - Expediting Plans to Advance CT1812 into Late-Stage Trials…
- Pursuing Divestiture of CertainT® Platform, Implements Changes to Corporate Leadership -- Build-out of GMP Manufacturing Facility to be Completed…
Hemostemix is revolutionizing how individuals think about their own regenerative medicine treatments. With social media, the company is educating about…
Strategic agreements set the stage for further global adoption of portable MR brain imaging technology, fueling expansion plans for 2025.GUILFORD,…
Strategic agreements set the stage for further global adoption of portable MR brain imaging technology, fueling expansion plans for 2025.GUILFORD,…
VANCOUVER, Washington, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Dear Shareholders, As I look back on 2024, during which CytoDyn Inc.…